Figure 3
From: A pan-cancer analysis of the role of hexokinase II (HK2) in human tumors
Mutation feature of HK2 in different tumors of TCGA. The mutation features of HK2 for the TCGA tumors were analyzed using the cBioPortal tool. The alteration frequency with mutation type (a) and mutation site (b) are displayed. The mutation site (V431Cfs*26, L795Rfs*10, and A901Rfs*74) in the 3D structure of HK2 were also displayed (b). The potential correlation between mutation status and overall, disease-specific, disease-free, and progression-free survival of UCEC (c) was also analyzed using the cBioPortal tool.
